Viveve Medical, Inc.
VIVE · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $115,022,831 | $73,955,816 | $48,287,358 | $326,119,500 |
| - Cash | $19,162 | $6,523 | $13,308 | $29,523 |
| + Debt | $5,349 | $5,993 | $4,251 | $30,528 |
| Enterprise Value | $115,009,018 | $73,955,286 | $48,278,301 | $326,120,505 |
| Revenue | $6,426 | $5,479 | $6,567 | $18,517 |
| % Growth | 17.3% | -16.6% | -64.5% | – |
| Gross Profit | $620 | $296 | $1,016 | $7,320 |
| % Margin | 9.6% | 5.4% | 15.5% | 39.5% |
| EBITDA | -$19,632 | -$19,325 | -$30,679 | -$44,166 |
| % Margin | -305.5% | -352.7% | -467.2% | -238.5% |
| Net Income | -$22,027 | -$21,915 | -$42,526 | -$49,182 |
| % Margin | -342.8% | -400% | -647.6% | -265.6% |
| EPS Diluted | -2.65 | -16.56 | -121.91 | -1,583.5 |
| % Growth | 84% | 86.4% | 92.3% | – |
| Operating Cash Flow | -$12,878 | -$15,234 | -$31,236 | -$43,090 |
| Capital Expenditures | -$456 | -$781 | -$1,087 | -$2,142 |
| Free Cash Flow | -$13,334 | -$16,015 | -$32,323 | -$45,232 |